chr7-94425664-G-A

Variant summary

Our verdict is Likely pathogenic.
+8 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 8 classification points (ACMG Germline Pathogenicity v2019). PVS1_ModeratePM2PP5_Strong

The NM_000089.4(COL1A2):c.2835+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. This is a canonical splice-site variant (loss-of-function). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.75). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

COL1A2
NM_000089.4 splice_donor, intron

Scores

6
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 9.75

Publications

2 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • COL1A2-related Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • COL1A2-related osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Illumina, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Genomics England PanelApp
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital heart disease
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000089.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 8 points.

PVS1Null variant in LOF gene
Non-NMD splice frameshift: disease mechanism, small exon — moderate (PVS1 downgraded to PM); Splice donor variant predicted to cause a frameshift; NMD not predicted. Loss of function is a known disease mechanism, but the exon is small.
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (threshold 0.0001) — PM2 moderate.
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000089.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

COL1A2 NM_000089.4
MANE Select
HGVSc / HGVSpc.2835+1G>A
Exon rankIntron 43 of 51
splice_donorintron
Prot: NP_000080.2

Ensembl Transcripts

COL1A2 ENST00000297268.11
TSL:1MANE Select
HGVSc / HGVSpc.2835+1G>A
Exon rankIntron 43 of 51
splice_donorintron
Prot: ENSP00000297268.6UniProt: P08123
COL1A2 ENST00000959377.1
HGVSc / HGVSpc.2832+1G>A
Exon rankIntron 43 of 51
splice_donorintron
Prot: ENSP00000629436.1UniProt: A0ACI8V6J0
COL1A2 ENST00000959379.1
HGVSc / HGVSpc.2835+1G>A
Exon rankIntron 43 of 51
splice_donorintron
Prot: ENSP00000629438.1UniProt: A0ACI8V5G4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:32
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Osteogenesis imperfecta with normal sclerae, dominant form (2)
1
-
-
Osteogenesis imperfecta type I (1)
1
-
-
Osteogenesis imperfecta type I;C0268335:Ehlers-Danlos syndrome, classic type, 1 (1)
1
-
-
See cases (1)

Computational Scores

AlphaGenome AVI
Pathogenic32
BayesDel_addAF
Pathogenic0.60D
BayesDel_noAF
Pathogenic0.39
CADD
Pathogenic34
DANN
Uncertain1.0
Eigen
Pathogenic1.3
Eigen_PC
Pathogenic1.1
FATHMM_MKL
Pathogenic0.98D
GPN-Star LLR
N/A-9.1
GPN-Star score
N/A9.1
Mutation Taster
N/A0/100disease causing (ClinVar)
PhyloP100
Pathogenic9.8
Showing 12 of 12 scores

Splicing Scores

dbscSNV1_ADA
Pathogenic1.0
dbscSNV1_RF
Pathogenic0.94
DS_DG_spliceai
Uncertain0.31
Position offset: 3
DS_DL_spliceai
Pathogenic0.83
Position offset: -1
Pangolin (max)
Pathogenic0.86
Pangolin loss
Pathogenic0.86
Position offset: -1
SpliceAI score (max)
Pathogenic0.83
Details are displayed if max score is > 0.2
Showing 7 of 7 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.